Financhill
Back

Channel Therapeutics Stock Predictions

Channel Therapeutics Stock Forecast

  • Is Channel Therapeutics Stock Undervalued?
    The current Channel Therapeutics [CHRO] share price is $0.97. The Score for CHRO is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
  • CHRO is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.

Will Channel Therapeutics Stock Go Up Next Year?

Data Unavailable

Channel Therapeutics Stock Rating

Data Unavailable

Channel Therapeutics Stock Price History

Is CHRO stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CHRO is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NYAM
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
channeltherapeutics.com

52-Week Data

52-Week High:
3.80
52-Week Low:
0.45

Prediction Charts

Market Cap:
5.6M
Price in USD:
0.97
Volume:
16.3K
Beta:
4.38

Technical Analysis

SMA50:
1.28
SMA100:
1.52
SMA200:
1.12
52-Wk Change:
-29.04%

Stock Predictions

  • Is Channel Therapeutics stock public?
    Yes, Channel Therapeutics is a publicly traded company.
  • What is the Channel Therapeutics stock quote today?
    The Channel Therapeutics stock price is 0.97 USD today.
  • How to buy Channel Therapeutics stock online?
    You can buy Channel Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-8 1.15 1.12 1.15 1.09
May-9 1.12 1.10 1.13 1.02
May-12 1.05 1.08 1.09 0.95
May-13 1.03 1.07 1.14 1.03
May-14 0.92 1.06 1.10 0.91
May-15 1.00 0.96 1.02 0.92
May-16 1.01 1.00 1.05 0.97
May-19 0.96 1.05 1.12 0.96
May-20 1.05 1.03 1.06 0.97
May-21 1.03 0.99 1.03 0.97
May-22 1.01 0.96 1.01 0.93
May-23 0.93 0.97 1.01 0.91
May-27 1.02 0.97 1.05 0.97
May-28 0.97 0.97 0.99 0.92

Channel Therapeutics Earnings

Data Unavailable

Channel Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and an increase next year of $0.05 per share.

* Channel Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.